A Pilot Study of Acupuncture to Control Symptoms in Patients Receiving Stem Cell Transplantation for Multiple Myeloma

Protocol
13-038
Full Title
Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients: A Pilot Study
Phase
Pilot
Purpose

Patients who receive chemotherapy and a stem cell transplant may experience anxiety, sleep problems, nausea/vomiting, and fatigue. Acupuncture may help relieve some of these symptoms. The purpose of this study is to see if acupuncture is helpful for controlling symptoms in patients with multiple myeloma who are receiving chemotherapy and an autologous stem cell transplant (return of their own stem cells after chemotherapy).

Patients will be randomly assigned to one of two groups: One group will receive traditional acupuncture, and the other group will receive an acupuncture-like procedure that creates the same sensation. Both groups will receive their treatments once a day for five days starting the day after chemotherapy. Researchers will compare symptoms between the two groups.

Eligibility

This study will include patients age 21 and older being treated for multiple myeloma with conditioning chemotherapy followed by autologous stem cell transplantation. Patients may not have had acupuncture in the 4 weeks before entering the study.

For more information about this study, please contact Ben Search, the Research Study Assistant, at 646-888-0810.

Disease(s)
Blood & Marrow Stem Cell Transplantation
Blood & Marrow Stem Cell Transplantation: Autologous
Hematology: Multiple Myeloma
Locations